Progression of Duchenne Cardiomyopathy Presenting with Chest Pain and Troponin Elevation

Kan N Hor1, Pace Johnston1, Kathi Kinnett2

  • 1Nationwide Children's Hospital, Columbus, OH, USA.

Insights

Acute chest pain with elevated troponin I (cTn) in Duchenne muscular dystrophy (DMD) boys may signal worsening cardiomyopathy. This under-recognized presentation indicates acute left ventricular dysfunction and myocardial fibrosis progression in DMD patients.

Area of Science:

  • Cardiology
  • Neuromuscular Disorders
  • Biomarkers

Background:

  • Duchenne muscular dystrophy (DMD) management advances have shifted mortality causes to progressive cardiomyopathy.
  • Troponin I (cTn) levels are typically not elevated in asymptomatic DMD patients despite cardiac imaging findings.

Purpose of the Study:

  • To describe the clinical presentation and cardiac findings in Duchenne muscular dystrophy (DMD) boys experiencing acute chest pain (ACP) with elevated troponin I (cTn).
  • To investigate the association between ACP, cTn elevation, and cardiomyopathy progression in DMD.

Main Methods:

  • Case series of eight boys with DMD presenting with acute chest pain (ACP) and elevated troponin I (cTn).
  • Evaluation included electrocardiograms (ECG), cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement (LGE), and serial cTn measurements.
  • Left ventricular ejection fraction (LVEF) was assessed via echocardiography and CMR.

Main Results:

  • Eight DMD boys presented with ACP and acute cTn elevation (mean peak 44±15.4 ng/mL).
  • CMR revealed increased LGE (12.4% to 36.5%) and decreased LVEF (61% to 47.6%), which remained depressed on follow-up.
  • cTn levels normalized with supportive care; viral studies were negative.

Conclusions:

  • Acute chest pain (ACP) with troponin I (cTn) elevation is a recognized clinical event in Duchenne muscular dystrophy (DMD) boys.
  • This presentation signifies acute left ventricular dysfunction and potential progression of myocardial fibrosis, indicating cardiomyopathy advancement.
  • These events may represent a critical pathophysiological mechanism in DMD cardiomyopathy progression.
Abstract

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
287
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
316
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
393
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
449